Interval sprinting and fat loss in overweight wome
Not Applicable
- Conditions
- Metabolic syndromePrevention of type 2 diabetesOverweight/ObesityMetabolic and Endocrine - Metabolic disordersDiet and Nutrition - ObesityMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12614001023640
- Lead Sponsor
- SW
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Free of heart disease or any other disease that would prevent exercise training, BMI between 28 and 35. No recent history of exercise training. Age between 45 and 55 years. A normal resting ECG.
Exclusion Criteria
Type 2 diabetes, smoker, history of heart disease and any other disease that would prevent exercise training, BMI of less than 28 or greater than 35, any medication that would negatively interact with exercise training (eg beta blockers), age less than 45 years or greater than 55 years. An abnormal resting ECG.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total body fat loss. This will be assessed by DEXA pre and post intervention. [DEXA will be performed before and after the 8-week intervention.];Insulin sensitivity. This will be assessed by a glucose tolerance test. [A GTT before and after the 8-week intervention.];Visceral fat. This will be assessed by bioelectrical impedance (Tanita Viscan). [Assessed before and after the 8-week intervention and during the intervention (weeks 2, 3, 4, 5, 6, 7).]
- Secondary Outcome Measures
Name Time Method Baroreceptor sensitivity assessed by software measuring the rise and fall of systolic blood pressure and heart rate.[Assessed before and after the 8-week intervention];Cardiac output and stroke volume measured by impedance cardiography.[Assessed before and after the 8-week intervention.]